Hoffmann Chelsey, Wang Jinlan, Ali Rushna P, D'Souza Ryan S
Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Department of Spine, Mayo Clinic, Rochester, Minnesota, USA.
Biomol Biomed. 2025 Jan 14;25(2):304-313. doi: 10.17305/bb.2024.10967.
Neuromodulation is being utilized across a variety of medical subspecialties to treat both painful and non-painful medical conditions. However, publications on neuromodulation topics infrequently occur in journals targeting generalists and medical specialties outside of pain medicine and neurosurgery. This study reviewed implantable neuromodulation devices, their respective Food and Drug Administration-approved indications for use, as well as off-label usage, and the associated potential risks and benefits for each device. PubMed and Medline databases were queried for systematic reviews with or without meta-analyses and randomized controlled trials of implantable neuromodulation devices. The literature review resulted in 106 studies eligible for inclusion, and 67 were included in the final review. In conclusion, as the clinical volume of neuromodulation continues to grow, supporting and educating medical professionals who care for patients that receive implanted neuromodulation devices is paramount. It is likely the use of neuromodulation will continue to expand across all medical subspecialties, and as such, every clinician should have a baseline understanding of this treatment.
神经调节正在被应用于各种医学亚专业,以治疗疼痛性和非疼痛性疾病。然而,关于神经调节主题的出版物很少出现在面向全科医生以及疼痛医学和神经外科以外的医学专业的期刊上。本研究回顾了可植入神经调节设备、它们各自获得美国食品药品监督管理局批准的使用适应症、以及标签外使用情况,以及每种设备相关的潜在风险和益处。通过检索PubMed和Medline数据库,查找有关可植入神经调节设备的系统评价(有无Meta分析)和随机对照试验。文献回顾产生了106项符合纳入标准的研究,最终纳入67项进行综述。总之,随着神经调节的临床应用量持续增长,支持和培训照顾接受植入式神经调节设备患者的医学专业人员至关重要。神经调节的应用可能会继续在所有医学亚专业中扩展,因此,每位临床医生都应该对这种治疗方法有基本的了解。